Hao Lou

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Molecular Dynamics

Top Venues

Molecular pharmaceutics

Analytical methods : advancing methods and applications

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Lou, Yaqi Wu, Krzysztof Kuczera, Christian Schöneich
Coarse-Grained Molecular Dynamics Simulation of Heterogeneous Polysorbate 80 Surfactants and their Interactions with Small Molecules and Proteins. Molecular pharmaceutics (2024)
Hao Lou, Yilue Zhang, Krzysztof Kuczera, Michael J Hageman, Christian Schöneich
Molecular Dynamics Simulation of an Iron(III) Binding Site on the Fc Domain of IgG1 Relevant for Visible Light-Induced Protein Fragmentation. Molecular pharmaceutics (2023)
Hao Lou, Li Ding, Tian Wu, Weikun Li, Ryan Khalaf, Hugh D C Smyth, Darren L Reid
Emerging Process Modeling Capabilities for Dry Powder Operations for Inhaled Formulations. Molecular pharmaceutics (2023)
Hao Lou, Yilue Zhang, Krzysztof Kuczera, Michael J Hageman, Christian Schöneich
Molecular Dynamics Simulation of an Iron(III) Binding Site on the Fc Domain of IgG1 Relevant for Visible Light-Induced Protein Fragmentation. Molecular pharmaceutics 21 (2) (2023)
Hao Lou, Yilue Zhang, Krzysztof Kuczera, Michael J Hageman, Christian Schöneich
Molecular Dynamics Simulation of an Iron(III) Binding Site on the Fc Domain of IgG1 Relevant for Visible Light-Induced Protein Fragmentation. Molecular pharmaceutics 21 (2) (2023)
Hao Lou, Michael J Hageman
Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment. Molecular pharmaceutics 19 (11) (2022)
Hao Lou, Michael J Hageman
Investigating protein diffusivities in diluted hyaluronic acid solutions using dynamic light scattering. Analytical methods : advancing methods and applications 14 (3) (2022)
Hao Lou, Michael J Hageman
Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies. Pharmaceutical research 38 (3) (2021)